CCOPS Unhappy With NCI Policy Limiting Their Participation In Early Phase 2 Clinical Trials
In Brief: Oldham to Leave NCI, Herberman Acting Head Of BRMP; Lansky Appointed Director Of ICC
Cooperative Groups Not Included Among Grants to Be Funded At Recommended Levels
“Withheld” News Release On QRA Policies Released
CCRU, CCSP Projects Described; Plans Listed for DRCCA Applications Branch
DRCCA Board Oks Noncompetitive Contract Concepts
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









